Document:

EX-10.1

 Exhibit 10.1 

October 11, 2017 
 Ultra SC Inc. 

1775 Tysons Boulevard 
 Tysons, Virginia 22102 

Veritas Capital Fund Management, L.L.C. 
 9 West 57th Street,
29th Floor 
 New York, NY 10019 
 KGS Holding LLC 

9 West 57th Street, 29th Floor 
 New York, NY 10019 

The SI Organization Holdings LLC 
 9 West 57th Street, 29th Floor

 New York, NY 10019 
 Ladies and Gentlemen: 

Reference is made to that certain Agreement and Plan of Merger dated as of October 11, 2017 (the “Merger Agreement”) by and among DXC
Technology Company, a Nevada corporation (“Delta”), Ultra SC Inc., a Nevada corporation and a direct, wholly owned subsidiary of Delta (“Ultra”), Ultra First VMS Inc., a Delaware corporation and a direct, wholly
owned subsidiary of Ultra, Ultra Second VMS LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of Ultra, Ultra KMS Inc., a Delaware corporation and a direct, wholly owned subsidiary of Ultra, Vencore Holding Corp., a
Delaware corporation (“Vector”), KGS Holding Corp., a Delaware corporation (“Kodiak”), The SI Organization Holdings LLC, a Delaware limited liability company, and KGS Holding LLC, a Delaware limited liability
company. Pursuant to the Merger Agreement, equityholders of Vector and Kodiak, including funds managed by Veritas Capital Fund Management, L.L.C., a Delaware limited liability company (“Sponsor”), will receive as consideration
shares of common stock of Ultra, $0.01 par value per share (“Ultra Common Stock”). 
 Each of Ultra, Sponsor and the Enumerated
Stockholders is referred to herein as a “Party” and, together, as the “Parties.” Unless otherwise specified herein, capitalized terms used in this letter agreement (this “Agreement”) but not defined
herein shall have the meanings set forth for such terms in the Merger Agreement. 
 In consideration of the mutual covenants contained herein and other good
and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: 
  

 PART I — REGISTRATION RIGHTS 

 

	1.	DEFINED TERMS 

  

	1.1	Definitions 

 When used in Part I of this Agreement, the following terms shall
have the respective meanings specified therefor below (such meanings to be equally applicable to both the singular and plural forms of the terms defined). 

“Blackout Period” shall mean a Close Period or a Discretionary Blackout Period. 

“Close Period” shall mean the period that begins fifteen days prior to the end of a fiscal quarter and ends on the day
following the first public announcement of the results for such fiscal quarter. 
 “Discretionary Blackout Period” means a
period of up to 45 days in a 180 day period in the event that (a) the SEC issues a stop order suspending the effectiveness of any registration statement with respect to Registrable Securities or the initiation of proceedings with respect to
such registration statement under Section 8(d) or 8(e) of the Securities Act, provided that such Discretionary Blackout Period shall automatically terminate at such earlier time as such stop order has been lifted or shall cease to be effective
or the SEC has determined not to issue a stop order in such proceeding, or (b) Ultra’s Board of Directors determines in its good faith judgment that the registration or sale of Registrable Securities would reasonably be expected to
materially adversely affect or materially interfere with any bona fide material financing of Ultra or any material transaction under consideration by Ultra or would require disclosure of information that has not been, and is not otherwise required
to be, disclosed to the public, the premature disclosure of which would materially adversely affect Ultra. 
 “FINRA” shall
mean the Financial Industry Regulatory Authority (or any successor thereto). 
 “Free Writing Prospectus” shall mean a
free-writing prospectus, as defined in Rule 405. 
 “Permitted Transferee” shall mean (i) any Affiliate of Sponsor, or
(ii) any successor entity; provided that, in each case described in clauses (i) and (ii), only to the extent such transferee agrees to be bound by the terms of this Agreement in accordance with the provisions hereof. 

“Prospectus” means the prospectus included in a Shelf Registration Statement, all amendments and supplements to the
Prospectus, including post-effective amendments, all material incorporated by reference or deemed to be incorporated by reference in such Prospectus and any Free Writing Prospectus. 

“Registrable Securities” shall mean all shares of Ultra Common Stock issued to Sponsor or its Affiliates pursuant to the
Merger Agreement (and any shares or other securities issued or distributed in respect thereof by way of a split, combination or dividend or in connection with a merger, consolidation, conversion, business combination, recapitalization,
reclassification, reorganization and/or exchange); provided that such securities will continue to be Registrable Securities in the hands of any Permitted Transferee thereof, and, other than in the hands of any Permitted Transferee, such securities
will cease to be Registrable Securities: (i) when they have been effectively registered under the Securities Act and disposed of in accordance with such registration statement covering them or (ii) when they have been sold to the public in
accordance with Rule 144 or other exemption from registration under the Securities Act. 

  
 2 

 “Rule 405” shall mean SEC Rule 405 under the Securities Act, as Rule 405 may be
amended from time to time, or any similar successor rule that may be issued by the SEC. 
 “Rule 415” shall mean SEC Rule
415 under the Securities Act, as Rule 415 may be amended from time to time, or any similar successor rule that may be issued by the SEC. 

“Rule 424” shall mean SEC Rule 424 under the Securities Act, as Rule 424 may be amended from time to time, or any similar
successor rule that may be issued by the SEC. 
 “Shelf Registration” means the registration of an offering of Registrable
Securities on a Form S-1 Shelf or a Form S-3 Shelf, as applicable, on a delayed or continuous basis under Rule 415 under the Securities Act, pursuant to
Section 2.1. 
 “Transfer” shall mean any sale, pledge, assignment, encumbrance or other transfer
or disposition of any Registrable Securities (or any voting or economic interest therein) to any other Person, whether directly, indirectly, voluntarily, involuntarily, by operation of law, pursuant to judicial process or otherwise. 

“Underwritten Offering” shall mean a bona fide underwritten registered public offering of any Registrable Securities. 

 

	2.	REGISTRATIONS 

  

	2.1	Shelf Registration Statement 

 On or prior to the Initial Date (as defined below), Ultra
shall file a Registration Statement for a Shelf Registration on Form S-1 covering the resale of all Registrable Securities on a delayed or continuous basis (the “Form
S-1 Shelf”). In the event that Ultra becomes eligible to use Form S-3 under the Securities Act after twelve (12) calendar months following the Closing
Date, Ultra shall use its commercially reasonable efforts to convert the Form S-1 Shelf to a Shelf Registration on Form S-3 (a “Form S-3 Shelf” and together with the Form S-1 Shelf, the “Shelf Registration Statement”) or, if such conversion is not permitted, shall file a new
Registration Statement that is a Form S-3 Shelf. Subject to the terms of this Agreement, including any applicable Blackout Period, Ultra shall respond to any comments from the SEC as promptly as practicable
and use its commercially reasonable efforts to cause the Shelf Registration Statement to be declared effective under the Securities Act as promptly as practicable after the filing thereof and shall use its commercially reasonable efforts to keep
such Shelf Registration Statement continuously effective under the Securities Act until the date that all Registrable Securities covered by such Registration Statement are no longer Registrable Securities (the period during which Ultra shall use its
commercially reasonable efforts to keep the Shelf Registration Statement continuously effective under the Securities Act in accordance with this Section 2.1 the “Shelf Period”). Ultra shall notify the
holders of Registrable Securities named in the Shelf Registration Statement via facsimile or by email of the effectiveness of a Form S-1 Shelf promptly once Ultra confirms effectiveness with the
SEC. Ultra shall file a final Prospectus with the SEC to the extent required by Rule 424. The “Plan of Distribution” section of such Shelf Registration Statement shall provide for all permitted means of disposition of Registrable
Securities requested in writing to be included therein by Sponsor including, without limitation, Underwritten Offerings, agented transactions, sales directly into the market, purchases or sales by brokers and sales not involving a public offering.

  
 3 

	2.2	Requests for Registration 

 Subject to Article 3 of Part
I of this Agreement and the other terms and conditions of Part I of this Agreement, at any time during the Shelf Period, Sponsor may request to sell all or any portion of the Registrable Securities in an offering that is registered
pursuant to the Shelf Registration Statement (each, a “Shelf Takedown”). Sponsor may request Ultra to initiate up to five Shelf Takedowns that are Underwritten Offerings. For the avoidance of doubt, there shall be no limit on
resales by Sponsor pursuant to any Shelf Registration Statement that are not Shelf Takedowns that are Underwritten Offerings. An offering using any such registration statement may be an Underwritten Offering if requested by Sponsor. 

 

	2.3	Shelf Takedown Notice 

 All requests for Shelf Takedowns shall be made only by Sponsor
giving written notice to Ultra (a “Shelf Takedown Notice”). Each Shelf Takedown Notice shall specify the number of Registrable Securities to be sold and the intended methods of disposition. For the avoidance of doubt, a Shelf
Takedown Notice may be given by Sponsor during a Blackout Period with such Shelf Takedown, at the option of Sponsor, to occur immediately following the next succeeding Business Day following expiration of the Blackout Period. In addition, in the
event of a Blackout Period, Sponsor shall have the right to withdraw its Shelf Takedown Notice and, if such Shelf Takedown Notice is withdrawn, such Shelf Takedown shall not be taken into account for purposes of any limitations applicable thereto in
this Agreement, and Ultra shall pay all reasonable expenses in connection with such withdrawn Shelf Takedown and registration. 
  

	2.4	Priority on Shelf Registrations 

 During the term of Part I of this Agreement,
Ultra shall not include in any Shelf Takedown any securities that are not Registrable Securities without the prior written consent of Sponsor, which consent shall not be unreasonably withheld, conditioned or delayed. In any Underwritten Offering, if
the managing underwriter(s) advises Ultra in writing that in its opinion the number of Registrable Securities and, if permitted hereunder, other securities requested to be included in such Underwritten Offering exceeds the number of Registrable
Securities and other securities, if any, that can be sold therein in an orderly manner at a price that is acceptable to Sponsor, then Ultra shall include in such registration only such number of shares of Ultra Common Stock that in the opinion of
the managing underwriter(s) can be sold in an orderly manner at a price that is acceptable to Sponsor, which shares shall be included in the following order of priority: 
  

	 	(a)	first, Registrable Securities for which registration was requested; 

  

	 	(b)	second, any securities proposed to be registered by Ultra; and 

  

	 	(c)	third, any other securities proposed to be included in such registration which, in the opinion of the underwriters, can be sold without any such adverse effect. 

 

	2.5	Selection of Underwriters 

 Sponsor shall have the right to select the underwriter or
underwriters to administer any Underwritten Offering in connection with a sale of Registrable Securities pursuant to a Shelf Takedown from a list to be supplied by Ultra, which list shall include at least five nationally recognized investment
banking firms. If Sponsor wishes to select a lead underwriter that is not on the list provided by Ultra, Sponsor may propose an alternative lead underwriter; provided however that if Ultra objects in good faith to such alternative lead underwriter,
Ultra may require Sponsor to select a different alternative lead underwriter after good faith consultation with Ultra, and, for the avoidance of doubt, Ultra may not object to such different alternative lead underwriter. 

  
 4 

	2.6	Other Registration Rights 

 Ultra represents and warrants that it is not a party to, or
otherwise subject to, any other agreement granting registration rights to any Person with respect to any securities of Ultra other than this Agreement. After the date hereof, Ultra shall not enter into any agreement or arrangement with any current
or future holder of securities that would cause Ultra to be unable to comply with its obligations under Part I of this Agreement. 
  

	3.	RESTRICTIONS ON REGISTRATIONS 

  

	3.1	Restrictions on Registrations 

 Ultra will not be obligated to effect more than one
Shelf Takedown that is an Underwritten Offering in any 90 day period or more than three Shelf Takedowns that are Underwritten Offerings in any 365 day period. Ultra shall not be obligated to effect any Shelf Takedown that is an Underwritten Offering
unless the reasonably anticipated gross proceeds from the sale of Registrable Securities in such Shelf Takedown that is an Underwritten Offering are $100 million. Notwithstanding anything in this Agreement to the contrary, no Registrable
Securities may be registered, offered, sold or otherwise transferred under, and Ultra shall not be required to maintain the effectiveness of, more than one registration statement with respect to Registrable Securities at any time nor shall Ultra be
required, beginning eighteen months after the Closing Date, to maintain a Shelf Registration Statement once the fair market value of all Registrable Securities is less than the lesser of (a) $100 million in the aggregate and (b) one
percent of the outstanding shares of Ultra Common Stock. 
  

	3.2	Right to Defer or Suspend Registrations 

 Notwithstanding anything to the contrary
contained in this Agreement, during any Blackout Period, Ultra shall be entitled, by providing written notice, to require any holder of Registrable Securities to suspend the use of any Prospectus for sales of Registrable Securities during such
Blackout Period. After the expiration of any Blackout Period and without any further request from Sponsor, Ultra shall provide prompt written notice to Sponsor and shall promptly terminate any suspension of sales it has put into effect and shall
take such other actions to permit registered sales of Registrable Securities as completed by this Agreement, including to the extent necessary shall as promptly as reasonably practicable and, if Sponsor has delivered a Shelf Takedown Notice during
any Blackout Period, the next succeeding Business Day following such expiration, prepare and file a post-effective amendment or supplement to the Shelf Registration Statement or the Prospectus, or any document incorporated therein by reference, or
file any other required document so that, as thereafter delivered to purchasers of the Registrable Securities included therein, the Prospectus will not include an untrue statement of a material fact or omit to state any material fact necessary to
make the statements therein, in the light of the circumstances under which they were made, not misleading. In the event of a Blackout Period, Sponsor shall have the right to withdraw its Shelf Takedown Notice and, if such Shelf Takedown Notice is
withdrawn, such Shelf Takedown shall not be taken into account for purposes of any limitations applicable thereto in this Agreement, and Ultra shall pay all reasonable expenses in connection with such withdrawn Shelf Takedown and registration. 

  
 5 

	4.	PIGGYBACK REGISTRATIONS 

  

	4.1	Right to Piggyback 

 If Ultra proposes to register any of its Ultra Common Stock
(whether or not in combination with any other equity or debt security or otherwise and whether or not in connection with a Shelf Registration) under the Securities Act (other than in connection with registration on Form S-4 or Form S-8 or any successor or similar forms, or relating solely to the sale of debt or convertible debt instruments) and the registration form to be used may be used for
the registration of Registrable Securities (a “Piggyback Registration”), Ultra shall give prompt written notice to Sponsor of its intention to effect such a registration. Each such notice shall specify the approximate number of
shares (or dollar amount) of Ultra Common Stock to be registered. Subject to Section 4.2, if Registrable Securities in the aggregate equal two percent or more of the outstanding shares of Ultra Common Stock, Ultra will
include in such registration (and in all related registrations or qualifications under blue sky laws and in any related underwriting) all Registrable Securities with respect to which Ultra has received a written request from Sponsor for inclusion
therein within 10 days after the delivery of such notice; provided that (i) Sponsor, if it participates in such offering, must sell its Registrable Securities to the underwriter or underwriters selected by Ultra in connection with such offering
on the same applicable terms and conditions as apply to Ultra and (ii) if, at any time after giving notice to Sponsor of its intention to effect such registration, Ultra shall determine for any reason not to register any of its Ultra Common
Stock under the Securities Act, Ultra shall give notice to Sponsor and thereupon shall be relieved of its obligation to register any Registrable Securities in connection with such registration and, except for the obligation to pay expenses pursuant
to Section 5.2 Ultra shall have no liability to Sponsor in connection with such termination or withdrawal. Ultra shall have the right to select the underwriter or underwriters to administer any underwritten offering in
connection with such registration and related offering. Sponsor shall have the right to withdraw its request for inclusion in such offering by giving written notice to Ultra up to and including the time of pricing of such offering. 

 

	4.2	Priority on Primary Registrations 

 If a Piggyback Registration is an underwritten
primary registration on behalf of Ultra, and the managing underwriter(s) advises Ultra that in its opinion the number of securities requested to be included in such registration exceeds the number which can be sold in such offering in an orderly
manner at a price that is acceptable to Ultra, Ultra will include in such registration only such number of shares of Ultra Common Stock that in the opinion of the managing underwriter(s) can be sold in an orderly manner at a price that is acceptable
to Ultra, which shares shall be included in the following order of priority: 
  

	 	(a)	first, the shares of Ultra Common Stock Ultra proposes to sell, 

  

	 	(b)	second, Registrable Securities requested to be included in such registration, and 

  

	 	(c)	third, any other shares of Ultra Common Stock requested to be included in such registration. 

  
 6 

	5.	REGISTRATION AND COORDINATION GENERALLY 

  

	5.1	Registration Procedures 

 Without limiting its obligations in
Section 2.1, Ultra will: 
  

	 	(a)	notify Sponsor of (i) the issuance by the SEC of any stop order suspending the effectiveness of any registration statement or the initiation of any proceedings for that purpose, (ii) the receipt by Ultra or
its counsel of any notification with respect to the suspension of the qualification of Registrable Securities for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose, and (iii) the effectiveness of each
registration statement filed hereunder; 

  

	 	(b)	prepare and file with the SEC such amendments and supplements to such registration statement and the prospectus used in connection therewith as may be necessary (i) in the case of a Shelf Registration, to keep such
registration statement updated and effective until such time that all Registrable Securities have been disposed of in accordance with the intended methods of disposition by such holder thereof set forth in such registration statement and
(ii) to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement until such time as all of such securities have been disposed of in accordance with the intended
methods of disposition by the seller or sellers thereof set forth in such registration statement; 

  

	 	(c)	furnish to Sponsor such number of copies of such registration statement, each amendment and supplement thereto, the prospectus included in such registration statement (including each preliminary prospectus), each
Prospectus, each Free Writing Prospectus and such other documents Sponsor may reasonably request in order to facilitate the disposition of Registrable Securities; 

 

	 	(d)	use its commercially reasonable efforts to register or qualify such Registrable Securities under such other securities or blue sky laws of such jurisdictions as Sponsor reasonably requests (provided that Ultra will not
be required to (i) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this subsection, (ii) subject itself to taxation in respect of doing business in any such jurisdiction, or
(iii) consent to general service of process in any such jurisdiction); 

  

	 	(e)	promptly notify Sponsor, at any time when a prospectus relating thereto is required to be delivered under the Securities Act, upon discovery that, or upon the discovery of the happening of any event as a result of
which, the prospectus included in such registration statement contains an untrue statement of a material fact or omits any fact necessary to make the statements therein not misleading in the light of the circumstances under which they were made,
and, at the request of Sponsor, Ultra will promptly prepare, file and furnish to Sponsor a reasonable number of copies of a supplement or amendment to such prospectus so that, as thereafter delivered to the prospective purchasers of such Registrable
Securities, such prospectus will not contain an untrue statement of a material fact or omit to state any fact necessary to make the statements therein not misleading in the light of the circumstances under which they were made; 

  
 7 

	 	(f)	cause all such Registrable Securities to be listed or quoted on each securities exchange on which similar securities issued by Ultra are then listed or quoted; 

 

	 	(g)	provide a transfer agent and registrar for all such Registrable Securities not later than the effective date of such registration statement; 

 

	 	(h)	enter into such customary agreements (including underwriting agreements in customary form) and perform Ultra’s obligations thereunder and take all such other actions as Sponsor or the managing underwriters, if any,
reasonably request in order to expedite or facilitate the disposition of such Registrable Securities; 

  

	 	(i)	in the case of an Underwritten Offering, make available for inspection by Sponsor, any managing underwriter participating in any disposition pursuant to such registration statement and any attorney or accountant
retained by Sponsor or any managing underwriter, all material financial and other records and pertinent corporate and business documents of Ultra as are reasonably necessary or reasonably requested by them to enable them to exercise their due
diligence responsibilities; 

  

	 	(j)	in the case of an Underwritten Offering, cooperate and participate as reasonably requested by Sponsor or the managing underwriter(s) in road show presentations or other customary selling efforts, in the preparation of
the registration statement, each amendment and supplement thereto, the prospectus included therein, and other activities as Sponsor or the managing underwriter(s) may reasonably request in order to facilitate the disposition of Registrable
Securities; 

  

	 	(k)	take all reasonable actions to ensure that each registration statement, prospectus or Free Writing Prospectus (if any) utilized in connection with any Shelf Registration or Piggyback Registration hereunder
(i) complies in all material respects with the Securities Act, (ii) is filed in accordance with the Securities Act to the extent required thereby and is retained in accordance with the Securities Act to the extent required thereby,
(iii) when taken together will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading, and (iv) in the case of such
prospectus or Free Writing Prospectus (when taken together with the related prospectus), will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading; 

  

	 	(l)	otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the SEC, and make available to its security holders, as soon as reasonably practicable, but not later than
eighteen (18) months after the effective date of the registration statement, an earnings statement covering the period of at least twelve (12) months beginning with the first day of Ultra’s first full calendar quarter after the
effective date of the registration statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 thereunder; 

 

	 	(m)	in the event of the issuance of any stop order suspending the effectiveness of a registration statement, or of any order suspending or preventing the use of any related prospectus or suspending the qualification of any
securities included in such registration statement for sale in any jurisdiction, Ultra will use its commercially reasonable efforts to promptly obtain the withdrawal of such order; 

  
 8 

	 	(n)	in the case of an Underwritten Offering, use its commercially reasonable efforts to obtain one or more comfort letters, signed by Ultra’s independent public accountants (and any other independent public accountants
who audited or reviewed financial information included in the applicable registration statement or prospectus) in the then-current customary form and covering such matters of the type customarily covered from time to time by comfort letters as the
managing underwriter(s) reasonably requests; 

  

	 	(o)	in the case of an Underwritten Offering, use its commercially reasonable efforts to provide a legal opinion and negative assurance letter of Ultra’s outside counsel, addressed to the managing underwriters, with
respect to the registration statement, each amendment and supplement thereto, the prospectus included therein (including the preliminary prospectus) and such other documents relating thereto in the then-current customary form and covering such
matters of the type customarily covered from time to time by legal opinions and negative assurance letters of such nature; 

  

	 	(p)	cooperate with the sellers of Registrable Securities covered by the registration statement and the managing underwriter(s), if any, to facilitate the timely preparation and delivery of certificates, if any (not bearing
any restrictive legends), representing securities to be sold under the registration statement, and enable such securities to be in such denominations and registered in such names as the managing underwriter(s), if any, or such holders may request;

  

	 	(q)	notify counsel for the Enumerated Stockholders and the managing underwriter(s), if any, promptly, and confirm the notice in writing (i) when the registration statement, or any post-effective amendment to the
registration statement, shall have become effective, or any supplement to the prospectus or any amendment prospectus shall have been filed, (ii) of the receipt of any comments from the SEC, (iii) of any request of the SEC to amend the
registration statement or amend or supplement the prospectus or for additional information, and (iv) of the issuance by the SEC of any stop order suspending the effectiveness of the registration statement or of any order preventing or
suspending the use of any preliminary prospectus, or of the suspension of the qualification of the registration statement for offering or sale in any jurisdiction, or of the institution or threatening of any proceedings for any of such purposes;

  

	 	(r)	use its commercially reasonable efforts to prevent the issuance of any stop order suspending the effectiveness of the registration statement or of any order preventing or suspending the use of any prospectus and, if any
such order is issued, use its commercially reasonable efforts to promptly obtain the withdrawal of such order; 

  

	 	(s)	in the case of an Underwritten Offering, if requested by the managing underwriter(s) or by Sponsor, promptly incorporate in a prospectus supplement or post-effective amendment such information as the managing
underwriter(s) or Sponsor reasonably requests to be included therein, including, with respect to the number of Registrable Securities being sold by each holder to such underwriter, the purchase price being paid therefor by such underwriter and with
respect to any other terms of the underwritten offering of Registrable Securities to be sold in such offering; and make all required filings of such prospectus supplement or post-effective amendment as soon as practicable after being notified of the
matters incorporated in such prospectus supplement or post-effective amendment; and 

  
 9 

	 	(t)	in the case of an Underwritten Offering, cooperate with Sponsor and each managing underwriter participating in the disposition of such Registrable Securities and their respective counsel in connection with any filings
required to be made with FINRA. 

 For purposes of the above paragraphs of this Section 5.1, an “Underwritten
Offering” shall include any offering that is a “bought deal” or a “broker-facilitated” transaction with one or more investment banks, and “managing underwriter” shall include any such investment banks. 

Ultra may require the Enumerated Stockholders to furnish in writing to Ultra such information relating to the sellers of Registrable
Securities and the sale or registration of Registrable Securities by the Enumerated Stockholders and the distribution thereof as Ultra may from time to time reasonably request in writing. In the event of a Piggyback Registration, if within 10 days
of the receipt of a written request from Ultra, the Enumerated Stockholders fail to provide to Ultra any information relating to the Enumerated Stockholders that is required by applicable law to be disclosed in any registration statement, Ultra may
exclude the Enumerated Stockholders Registrable Securities from such registration statement. 
 If any registration statement refers to any
holder by name or otherwise as the holder of any securities of Ultra and if in such holder’s sole and exclusive judgment, such holder is or might be deemed to be an underwriter or a controlling person of Ultra, such holder shall have the right
to require the insertion therein of language, in form and substance satisfactory to such holder and presented to Ultra in writing, to the effect that the holding by such holder of such securities is not to be construed as a recommendation by such
holder of the investment quality of Ultra’s securities covered thereby and that such holding does not imply that such holder will assist in meeting any future financial requirements of Ultra. 

 

	5.2	Registration Expenses 

 All reasonable fees and expenses incurred in the performance of
or compliance with this Agreement by Ultra including, without limitation, (a) all registration and filing fees (including, without limitation, fees and expenses (i) with respect to filings required to be made with the SEC, all applicable
securities exchanges and/or FINRA and (ii) of compliance with securities or blue sky laws, including, without limitation, any fees and disbursements of counsel for the underwriters in connection with blue sky qualifications of the Registrable
Securities pursuant to Section 5.1(d)), (b) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities in a form eligible for deposit with The Depository Trust Company and
of printing prospectuses if the printing of prospectuses is requested by the managing underwriter(s), if any, or by a holder making a Shelf Registration with respect to such offering), (c) messenger, telephone and delivery expenses of the Issuer,
(d) fees and disbursements of counsel for Ultra, (e) expenses of Ultra incurred in connection with any road show, (f) fees and disbursements of all independent registered public accounting firms referred to in
Section 5.1(n) hereof (including, without limitation, the expenses of any “cold comfort” letters required by this Agreement) and any other persons, including special experts retained by Ultra and (g) fees and
disbursements of separate counsel for the Enumerated Stockholders if they are participating in the offering (which counsel shall be selected by such participating Holders) shall be borne by Ultra whether or not any Registration Statement is filed or
becomes effective. In addition, Ultra shall pay its internal expenses (including, without limitation, all salaries and expenses of its officers and employees 

  
 10 

 
performing legal or accounting duties), the expense of any annual audit, the fees and expenses incurred in connection with the listing of the securities to be registered on any securities
exchange on which similar securities issued by Ultra are then listed and rating agency fees and the fees and expenses of any Person, including special experts, retained by Ultra. 

 

	5.3	Participation in Underwritten Offerings; Suspension of Dispositions 

  

	 	(a)	No Person may participate in any registration hereunder which is underwritten unless such Person (i) agrees to sell such Person’s securities on the basis provided in any underwriting arrangements approved by
the Person or Persons entitled hereunder to approve such arrangements (including, pursuant to the terms of any over-allotment or “green shoe” option requested by the managing underwriter(s), provided that no holder of Registrable
Securities will be required to sell more than the number of Registrable Securities that such holder has requested Ultra to include in any registration), (ii) completes and executes all questionnaires, powers of attorney, indemnities, underwriting
agreements and other documents reasonably required under the terms of such underwriting arrangements and (iii) cooperates with Ultra’s reasonable requests in connection with such registration. 

 

	 	(b)	Each Person that is participating in any registration hereunder agrees that, upon receipt of any notice from Ultra of the happening of any event of the kind described in Section 5.1(e) above,
such Person will forthwith discontinue the disposition of its Registrable Securities pursuant to the registration statement until such Person’s receipt of the copies of a supplemented or amended prospectus as contemplated by such
Section 5.1(e), as the case may be. In such case, such registration shall not be taken into account for purposes of any limitations applicable thereto in this Agreement, and Ultra shall pay all reasonable expenses described
in the first sentence of Section 5.3(a) in connection with such registration only insofar as such expenses are directly related to such Person’s discontinued disposition of Registrable Securities in accordance with a
notice from Ultra as described in the immediately prior sentence. 

  

	5.4	Current Information; Rule 144 Reporting 

 At all times after the date of this Agreement
and subject to any Blackout Period, Ultra will timely file all reports required to be filed by it under the Securities Act and the Exchange Act and the rules and regulations adopted by the SEC thereunder at any time when Ultra is subject to such
reporting requirements, all to the extent required to enable the Enumerated Stockholders to sell Registrable Securities pursuant to Rule 144. 
  

	6.	INDEMNIFICATION 

  

	6.1	Indemnification by Ultra 

 Ultra agrees to: (a) indemnify and hold harmless, to the
fullest extent permitted by law, the Enumerated Stockholders and, as applicable, their respective officers, directors, trustees, employees, unitholders, holders of beneficial interests, members, general and limited partners, agents and
representatives and each Person who controls the Enumerated Stockholders or such holder (within the meaning of the Securities Act) (collectively, “Sponsor Indemnitees”) against any and all losses, claims, actions, damages,
liabilities and expenses (including reasonable attorney’s fees and expenses), to which the Enumerated Stockholders or any such holder or Sponsor Indemnitee may become subject under the 

  
 11 

 
Securities Act or otherwise, insofar as such losses, claims, actions, damages, liabilities or expenses (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out
of, result from or are based upon (i) any untrue or alleged untrue statement of material fact contained in any registration statement of Ultra under the Securities Act that covers any Registrable Securities pursuant to this Agreement, or
prospectus or preliminary prospectus or any amendment thereof or supplement thereto relating to Registrable Securities, together with any documents incorporated therein by reference, or (ii) any omission or alleged omission of a material fact
required to be stated therein or necessary to make the statements therein (in the case of a prospectus or preliminary prospectus, in the light of the circumstances under which they were made) not misleading; and (b) reimburse the Enumerated
Stockholders and each such holder and Sponsor Indemnitee for any legal or any other expenses as incurred, including any amounts paid in any settlement effected with the consent of Ultra, which consent will not be unreasonably withheld or delayed,
reasonably incurred by them in connection with investigating or defending any such loss, claim, liability, action or proceeding; provided, however, that Ultra shall not be liable in any such case to the extent that any such loss, claim, action,
damage, liability or expense (or action or proceeding in respect thereof) arises out of, results from or is based upon an untrue statement or alleged untrue statement, or omission or alleged omission, made in such registration statement, any such
prospectus or preliminary prospectus or any amendment or supplement thereto, in reliance upon, and in conformity with, written information prepared and furnished to Ultra by or on behalf of such holder with respect to such holder expressly for use
therein. 
  

	6.2	Indemnification by Holders of Registrable Securities 

 In connection with any
registration statement in which a holder of Registrable Securities is participating, each such holder will furnish to Ultra in writing such information as Ultra reasonably requests for use in connection with any such registration statement,
prospectus, preliminary or prospectus and, to the extent permitted by law, will indemnify and hold harmless, severally and not jointly, Ultra and its officers, directors, employees, agents, representatives, trustees and each Person who controls
Ultra (within the meaning of the Securities Act) (collectively, the “Ultra Indemnitees”) against any losses, claims, damages, liabilities and expenses (including reasonable attorney’s fees and expenses) to which Ultra or any
such Ultra Indemnitee may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages, liabilities and expenses (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of, result
from or are based upon (a) any untrue or alleged untrue statement of material fact contained in any registration statement of Ultra under the Securities Act that covers any Registrable Securities pursuant to this Agreement, or prospectus,
preliminary prospectus or Free Writing Prospectus or any amendment thereof or supplement thereto relating to Registrable Securities, together with any documents incorporated therein by reference, or (b) any omission or alleged omission of a
material fact required to be stated therein or necessary to make the statements therein (in the case of a prospectus, preliminary prospectus or Free Writing Prospectus, in the light of the circumstances under which they were made) not misleading,
but, in the case of each of (a) and (b), only to the extent that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, any such prospectus, preliminary prospectus or Free
Writing Prospectus or any amendment thereof or supplement thereto, together with any documents incorporated therein by reference, in reliance upon and in conformity with written information prepared and furnished to Ultra by or on behalf of such
holder with respect to such holder expressly for use therein. In addition, such holder will reimburse Ultra and each such Ultra Indemnitee for any legal or any other expenses as incurred including any amounts paid in any settlement effected with the
consent of such holder, which consent will not be unreasonably withheld or delayed, incurred by them in connection with investigating or defending any such loss, claim, liability, action or proceeding. The liability of any holder of

  
 12 

 
Registrable Securities shall be several and not joint and shall be limited to the net proceeds after underwriting commissions and discounts (but before any taxes and expenses which may be payable
by such holder) received by such holder from the sale of Registrable Securities covered by such registration statement, less any other amounts paid by such holder to Ultra and each such Ultra Indemnitee in respect of such untrue statement, alleged
untrue statement, omission or alleged omission. 
  

	6.3	Procedure 

 Any Person entitled to indemnification hereunder will (a) give prompt
written notice to the indemnifying Party of any claim with respect to which it seeks indemnification (provided, that the failure of any indemnified Party to give such notice shall not relieve the indemnifying Party of its obligations hereunder,
except to the extent that the indemnifying Party is actually prejudiced by such failure to give such notice), and (b) unless in such indemnified Party’s reasonable judgment a conflict of interest between such indemnified and indemnifying
Parties may exist with respect to such claim, permit such indemnifying Party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified Party. If such defense is assumed, the indemnifying Party will not be subject to
any liability for any settlement made by the indemnified Party without its consent (but such consent will not be unreasonably withheld). An indemnifying Party who is not entitled to, or elects not to, assume the defense of a claim will not be
obligated to pay the fees and expenses of more than one counsel for all Parties indemnified by such indemnifying Party with respect to such claim, unless in the reasonable judgment of any indemnified Party a conflict of interest may exist between
such indemnified Party and any other of such indemnified Parties with respect to such claim. 
  

	6.4	Entry of Judgment; Settlement 

 The indemnifying Party shall not, except with the
approval of each indemnified Party, consent to entry of any judgment or enter into any settlement which does not include as an unconditional term thereof, the giving by the claimant or plaintiff to each indemnified Party of a release from all
liability in respect to such claim or litigation without any payment or consideration provided by such indemnified Party. 
  

	6.5	Contribution 

 If the indemnification provided for in this
Article 6 is, other than expressly pursuant to its terms, unavailable to or is insufficient to hold harmless an indemnified Party under the provisions above in respect of any losses, claims, damages, liabilities or expenses
referred to therein, then each indemnifying Party shall contribute to the amount paid or payable by such indemnified Party as a result of such losses, claims, damages, liabilities or expenses in such proportion as is appropriate to reflect the
relative fault of Ultra on the one hand and of the sellers of Registrable Securities and any other sellers participating in the registration statement on the other hand in connection with the statement or omissions which resulted in such losses,
claims, damages or liabilities, as well as any other relevant equitable considerations. The relative benefits received by the sellers of Registrable Securities and any other sellers participating in the registration statement shall be deemed to be
the total net proceeds from the offering (before deducting expenses) to the sellers of Registrable Securities and any other sellers participating in the registration statement. The relative fault of Ultra on the one hand, and of the sellers of
Registrable Securities and any other sellers participating in the registration statement on the other hand, shall be determined by reference to, among other things, whether the untrue or alleged statement or omission to state a material fact relates
to information supplied by Ultra or by the sellers of Registrable Securities or other sellers participating in the registration statement and the Parties’ relative intent, knowledge, access to information and opportunity to correct or prevent
such statement or omission. 

  
 13 

 Ultra and the sellers of Registrable Securities agree that it would not be just and equitable if
contribution pursuant to this Article 6 were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in the immediately preceding
paragraph. The amount paid or payable by an indemnified Party as a result of the losses, claims, damages, liabilities and expenses referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set forth
above, any legal or other expenses reasonably incurred by such indemnified Party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Article 6, no seller of
Registrable Securities shall be required to contribute any amount in excess of the net proceeds received by such seller from the sale of Registrable Securities covered by the registration statement filed pursuant hereto, less any other amounts paid
by such seller in respect of such untrue statement, alleged untrue statement, omission or alleged omission. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any Person who was not guilty of such fraudulent misrepresentation. 
  

	6.6	Other Rights 

 The indemnification and contribution by any such Party provided for under
this Agreement shall be in addition to any other rights to indemnification or contribution which any indemnified Party may have pursuant to law or contract and will remain in full force and effect regardless of any investigation made or omitted by
or on behalf of the indemnified Party or any officer, director or controlling Person of such indemnified Party and will survive the transfer of Registrable Securities and the termination or expiration of this Agreement. 

 

	6.7	Survival 

 The indemnification provided for under this Agreement will remain in full
force and effect regardless of any investigation made by or on behalf of the indemnified Party or any officer, agent or employee and each other Person who participates as an underwriter in the offering or sale of such securities and each other
Person, if any, who controls (within the meaning of the Securities Act) such indemnified Party, and will survive the transfer of securities. 
  

	7.	MISCELLANEOUS 

  

	7.1	Term; Termination 

 Part I of this Agreement will be effective as of the date
hereof and will continue in effect thereafter until the earliest of: (a) its termination by the written consent of the Parties hereto or their respective successors in interest; (b) the date on which Registrable Securities comprise fewer
than two percent of the outstanding shares of Ultra Common Stock; (c) the dissolution, liquidation or winding up of Ultra; and (d) the valid termination of the Merger Agreement upon the terms and subject to the conditions set forth
therein. 

  
 14 

	7.2	No Inconsistent Agreements 

 Ultra will not hereafter grant any registration rights with
respect to its securities that violate or are materially more favorable than the rights granted to the holders of Registrable Securities in this Agreement. 
  

	7.3	Permitted Transferees 

 Registrable Securities shall cease to be Registrable Securities
after any Transfer to any Person other than a Permitted Transferee. Prior to the Transfer of any Registrable Securities to any Permitted Transferee, and as a condition thereto, Sponsor shall cause such Permitted Transferee to deliver to Ultra its
written agreement, in form and substance reasonably satisfactory to Ultra, to be bound by the terms and conditions of this Agreement. 
  

	7.4	Dilution 

 If, from time to time, there is any change in the capital structure of Ultra
by way of a split, dividend, combination or reclassification, or through a merger, consolidation, reorganization or recapitalization, or by any other means, appropriate adjustment shall be made in the provisions hereof so that the rights and
privileges granted hereby shall continue. 
 PART II — CERTAIN COVENANTS 

 

	8.	LOCK-UP 

  

	8.1	Lock-Up Agreement 

  

	 	(a)	Other than with respect to a Permissible Transfer, Sponsor agrees that, without Ultra’s prior written consent, Sponsor will not, and will cause its controlled Affiliates, including, without limitation, the
Enumerated Stockholders not to, for a period commencing on the Closing Date and ending on the earlier of (i) January 1, 2019 and (ii) the date that is nine months following the Closing Date (such applicable date, the “Initial
Date”), (A) offer, pledge, sell, contract to sell, grant any option or contract to purchase, purchase any option or contract to sell, or otherwise dispose of, directly or indirectly, any shares of Ultra Common Stock or any securities
convertible into, exercisable for, or exchangeable for shares of Ultra Common Stock, or (B) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Ultra
Common Stock (the actions set forth in clauses (A) and (B), a “Transfer”), whether any such transaction described in clause (A) or (B) of this sentence is to be settled by delivery of common stock or such other
securities, in cash or otherwise. 

  

	 	(b)	Sponsor agrees that, without Ultra’s prior written consent, Sponsors will not, and will cause its controlled Affiliates, including, without limitation, the Enumerated Stockholders, not to, during the period
commencing on the Closing Date and ending on the Initial Date, make any demand for or exercise any right with respect to, the registration of any shares of Ultra Common Stock under Part I of this Agreement. 

  
 15 

	 	(c)	Other than with respect to a Permissible Transfer, Sponsor agrees that, without Ultra’s prior written consent, Sponsor will not, and will cause its controlled Affiliates, including, without limitation, the
Enumerated Stockholders not to, for a period commencing on the Initial Date and ending on the date that is the earlier of (i) April 1, 2019 and (ii) the date that is twelve months following the Closing Date, effect any Transfer that
would involve in the aggregate together with all other Transfers during such three-month period more than one-third of the total number of shares of Ultra Common Stock issued as Vector Stock Consideration and
Kodiak Stock Consideration, or any securities convertible into or, exercisable for, or exchangeable for such shares or any swap or other arrangement that transfers to another, in whole or in part, the economic consequences of ownership of such
securities (collectively in the aggregate a “Permitted One-Third”), whether any such Transfer is to be settled by delivery of common stock or such other securities, in cash or otherwise.

  

	 	(d)	Sponsor consents to the entry of stop transfer instructions with Ultra’s transfer agent and registrar relating to the transfer of the Sponsor’s and its controlled Affiliates’, including, without
limitation, the Enumerated Stockholders’, shares of Ultra Common Stock except in compliance with the restrictions set forth in this Section 8. 

 

	 	(e)	For purposes of this Section 3, “Permissible Transfer” means: 

  

	 	(i)	a Transfer of Ultra Common Stock by the Sponsor or one of its controlled Affiliates, on the one hand, to a controlled Affiliate of such Person, on the other hand; 

 

	 	(ii)	a Transfer of Ultra Common Stock as a result of any merger, consolidation or reorganization of Ultra; and 

  

	 	(iii)	a Transfer of Ultra Common Stock that constitutes a tender into a tender or exchange offer commenced by Ultra or approved and recommended by the Ultra Board of Directors. 

 

	9.	STANDSTILL 

  

	9.1	Standstill Agreement 

 Sponsor agrees that for a period commencing on the date of this
Agreement and ending on the earlier of (1) the first date that Sponsor and its controlled Affiliates collectively no longer own more than five percent of the total outstanding shares of Ultra Common Stock, (2) a material breach of
Section 11 hereof if such material breach has not been or is incapable of being cured within ten days after the receipt of written notice thereof and (3) upon a Fundamental Change Event (the “Standstill
Period”), none of Sponsor, its controlled Affiliates or any of their respective Representatives acting on their behalf shall in any manner, directly or indirectly or alone or in concert with any other person, in each case except (i) to
the extent approved by Ultra or (ii) as contemplated by this Agreement or any other Transaction Agreements (including the enforcement of any rights thereunder): 
  

	 	(a)	 effect or consummate or seek, agree, offer or propose (whether publicly or otherwise) to effect or consummate, or
announce any intention to effect or consummate or cause or participate in or in any way assist, facilitate or encourage any other person to effect or consummate or seek, agree, offer or propose (whether publicly or otherwise) to effect or consummate
or participate in (provided that, for the avoidance of doubt, any sale or any exchange or tender approved by the 

  
 16 

	 	
Ultra Board of Directors of Ultra Common Stock owned by Sponsor and its Affiliates as of the Closing Date (or otherwise acquired not in violation of this Agreement) shall not be subject to this
Section 9.1(a)): (i) any acquisition (by purchase or otherwise) of (A) any economic interest in, or any direct or indirect right to direct the voting or disposition of, any securities (or any derivative
securities) (or beneficial ownership thereof) of Ultra, or rights or options to acquire any securities (or any derivative securities) (or beneficial ownership thereof) of Ultra, or (B) except in the ordinary course of business, any assets,
indebtedness or businesses of Ultra or any of its Affiliates; (ii) any tender or exchange offer, merger or other business combination involving Ultra or any of its Affiliates or assets of Ultra or its Affiliates constituting a significant
portion of the consolidated assets of Ultra or any of its Affiliates, or (iii) any recapitalization, restructuring, liquidation, dissolution or other extraordinary transaction with respect to Ultra or any of its Affiliates unless such
transaction has been approved by the Ultra Board of Directors; 

  

	 	(b)	make, or in any way participate in, directly or indirectly, any solicitation of proxies to vote, or seek to advise or influence any person or entity with respect to the voting of, any voting securities of Ultra;

  

	 	(c)	initiate, induce or attempt to induce, cooperate or collaborate with, any other person, entity or group in connection with, any stockholder proposal or withhold vote campaigns or tender offers for equity securities of
Ultra, any change of control of Ultra or the convening of a meeting of Ultra Stockholders (other than in connection with a transaction that has been approved by the Ultra Board of Directors); 

 

	 	(d)	form, join or in any way participate in a group with respect to Ultra in respect of any securities of Ultra or in connection with (or otherwise act in concert with any person in connection with) the matters that are the
subject of this Section 9.1 (other than any group with a controlled Affiliate as a result of the ownership of Ultra Common Stock as of the Closing Date or acquired not in violation of this Agreement); 

 

	 	(e)	except as set forth in Section 11 hereof, otherwise act, alone or in concert with others, to seek representation on or to control or influence the management of Ultra, the Ultra Board of
Directors, or policies of Ultra or to obtain representation on the Ultra Board of Directors; 

  

	 	(f)	bring any action or otherwise act to contest the validity of this Section 9.1; 

  

	 	(g)	advise, assist, encourage, act as a financing source for or otherwise invest in any other person in connection with, or enter into any discussions, negotiations, arrangements or understandings with any other person with
respect to, any of the activities set forth in clauses (a) through (f) of this sentence or propose any of such activities to any other person; 

  

	 	(h)	publicly disclose any intention, plan or arrangement, or take any action, inconsistent with any of the foregoing; or 

  

	 	(i)	 take any action with respect to Ultra that would or would reasonably be expected to require Ultra to make a
public announcement regarding (i) any of the types of matters set forth in clauses (a) through (h) of this sentence, or (ii) the possibility of Sponsor or any other person acquiring control of Ultra, whether by means of a business
combination or otherwise. Any reference to “Ultra” in clauses (a) through (h) of the immediately preceding sentence shall be 

  
 17 

	 	
deemed to collectively refer to Ultra, any successor to Ultra (but in all respects subject to the Standstill Period). This Section 9.1 shall also apply with respect to
any of the foregoing activities with respect to any holding company that may subsequently be formed to hold Ultra and/or any of its assets (but in all respects subject to the Standstill Period). For purposes of this
Section 9.1, “derivative security” means, with respect to any person, any right, option, other security or other derivative position that has an exercise, exchange or conversion privilege or a settlement
payment or mechanism at a price related to, or a value determined in whole or in material part with reference to or derived in whole or in part from, the value of any securities, bank debt or other obligations of such person or any of its
subsidiaries (but, for the avoidance of doubt, shall not include any derivative transactions described in Section 7.9 of the Merger Agreement). 

 

	 	(j)	Notwithstanding anything to the contrary herein, in no event shall the restrictions set forth in this Section 9 be deemed to prohibit or otherwise restrict: (i) any actions of the Nominee
in its capacity as a member of the Ultra Board of Directors; (ii) any actions of Sponsor in connection with or contemplated by Section 11 of this Agreement; (iii) any action that is expressly permitted under the
terms of this Agreement or any Transaction Agreement (including the enforcement of any right arising thereunder); (iv) the voting or direction of voting, in the capacity as a stockholder, of any Ultra Common Stock by Sponsor or any of its controlled
Affiliates owned as of the Closing Date by Sponsor or its controlled Affiliates or acquired thereafter not in violation of this Agreement; (v) any acquisition of Ultra Common Stock or other securities pursuant to a dividend paid on Ultra Common
Stock or as a result of any merger, consolidation or recapitalization; or (vi) the filing of any Schedule 13D or similar disclosure by Sponsor or any of its controlled Affiliates reflecting the acquisition of Ultra Common Stock at the Closing
Date and stating any intention or plan that it may from time to time take actions permitted under this Section 9). 

  

	 	(k)	For purposes of this Section 9, a “Fundamental Change Event” means: (i) Ultra has entered into a definitive written agreement providing for a merger, consolidation, tender
offer, or exchange offer, or other business combination involving Ultra as a constituent party that would result in the acquisition of more than 50% of the Ultra’s outstanding equity securities; (ii) Ultra has entered into a definitive
written agreement providing for a sale of a majority or more of the Ultra’s assets; (iii) the second business day following a recommendation by the Ultra Board of Directors that Ultra’s stockholders tender or exchange their shares in
a bona fide tender offer or exchange offer for more than 50% of Ultra’s outstanding equity securities; or (iv) any transaction or series of related transactions or stockholder vote that results in the directors compromising the Ultra Board
of Directors immediately prior to such transaction or stockholder vote ceasing to represent the majority of directors compromising the Ultra Board of Directors; provided that any directors comprising the Ultra Board of Directors that were
nominated, elected, appointed or recommended by the Ultra Board of Directors immediately prior to such transaction or vote will be deemed to have been members of the Ultra Board of Directors after such vote or transaction. 

 

	9.2	No Waiver 

 Sponsor also agrees that neither it nor any of its Representatives acting on
its behalf shall, during the Standstill Period, publicly request that Ultra or any of its Representatives, directly or indirectly, (A) amend or waive any provision of this Article 9 (including this sentence) or (B) otherwise invite or
consent to any action inconsistent with any provision of this Article 9 including this sentence). 

  
 18 

	10.	TERM 

  

	10.1	Term; Termination 

 Part II of this Agreement will be effective as of the date
hereof and will continue in effect thereafter until the earliest of: (a) its termination by the written consent of the Parties hereto or their respective successors in interest; (b) the dissolution, liquidation or winding up of Ultra; and
(c) the valid termination of the Merger Agreement upon the terms and subject to the conditions set forth therein. 
 PART III
— DIRECTOR NOMINATIONS 
  

	11.	DIRECTOR NOMINATIONS 

  

	11.1	Director Nomination and Qualifications 

  

	 	(a)	At all times until Part III of this Agreement terminates pursuant to Section 12.1, Sponsor shall have the right (but not the obligation) to nominate one individual as a candidate for
election to the Ultra Board of Directors so long as (i) there is not then serving on the Ultra Board of Directors another individual previously nominated pursuant to this Agreement (a “Prior Nominee”) unless such Prior Nominee
has agreed in writing to resign effective upon the appointment of another individual nominated by Sponsor, (ii) such individual has been considered and approved by the Ultra’s nominating/corporate governance committee based on criteria
reasonably and consistently applied to all candidates for the Ultra Board of Directors and for eligibility of an issuer listed on a Stock Exchange, and (iii) such individual meets the director qualification standards to be contained in
Ultra’s corporate governance guidelines (an individual satisfying clauses (i) – (iii), a “Nominee”). Ultra (A) shall use its reasonable best efforts to have a Nominee appointed promptly following receipt by Ultra of a
written request from Sponsor to do so (which efforts shall include causing an increase in the size of the Ultra Board of Directors, if necessary and permissible under the Ultra by-laws as then in effect and
shall not be less than the efforts used by Ultra to obtain the election of any other director nominee nominated by it to serve as a director) and (B) shall include such Nominee in the slate of nominees recommended by the Ultra Board of
Directors to Ultra Stockholders for election as a director at the next (and if such Nominee is serving on the Ultra Board of Directors when the applicable proxy statement is filed and Part III of this Agreement has not terminated pursuant to
Section 12.1, each subsequent) annual or special meeting of the Ultra Stockholders at or by which directors of Ultra are to be elected (such efforts and actions in clauses (A) and (B) hereof, the “Ultra
Actions”), provided, however, for purposes of this clause (B), that such request is received at least ten business days before Ultra’s proxy statement for such next annual or special meeting has been filed with the SEC.
If Sponsor so requests in writing, Ultra shall (1) notify Sponsor of the date Ultra expects to file its proxy statement with the SEC in respect of Ultra’s next anticipated annual or special meeting of stockholders and (2) not
reschedule such SEC filing to an earlier date without providing notice to Sponsor at least fifteen business days prior to such rescheduled filing date. 

  
 19 

	 	(b)	If an individual nominated by Sponsor is determined not to be a Nominee or if a Nominee nominated by Sponsor is not appointed to the Ultra Board of Directors, Ultra shall notify Sponsor promptly in writing and, for the
avoidance of doubt, Sponsor will be permitted to continue to propose individuals for nomination in accordance with Section 11. 

  

	 	(c)	Upon termination of this Agreement, Sponsor shall use its reasonable best efforts to cause its nominee to resign from the Ultra Board of Directors as soon as reasonably practicable. 

 

	 	(d)	At the Effective Time, Ultra shall (i) take all actions necessary to appoint a chief executive officer of Ultra (the “CEO”) and (ii) undertake the Ultra Actions in connection with nominating
the CEO to the Ultra Board of Directors. For the avoidance of doubt, in no event shall the CEO be considered to be a Nominee. 

  

	12.	TERM 

  

	12.1	Term; Termination 

 Part III of this Agreement will be effective as of the
Closing Date and will continue in effect thereafter until the earliest of: (a) its termination by the written consent of the Parties hereto or their respective successors in interest; (b) Sponsor, together with its Affiliates, ceases to
hold a number of shares equal to at least 10% of the outstanding shares of Ultra Common Stock as of the Closing Date (such number of shares subject to customary anti-dilution adjustments); (c) the dissolution, liquidation or winding up of Ultra; and
(d) the valid termination of the Merger Agreement upon the terms and subject to the conditions set forth therein. 
 PART IV
— MISCELLANEOUS 
  

	13.	MISCELLANEOUS 

  

	13.1	Entire Agreement 

 This Agreement constitutes the full and entire understanding and
agreement between the Parties with regard to the subject matter hereof and supersedes all prior oral or written (and all contemporaneous oral) agreements or understandings with respect to the subject matter hereof. 

 

	13.2	Remedies 

 The Parties hereto agree and acknowledge that money damages may not be an
adequate remedy for any breach of the provisions of this Agreement and that, in addition to any other rights and remedies at law or in equity existing in its favor, any Party shall be entitled to specific performance and/or other injunctive relief
from any court of law or equity of competent jurisdiction (without posting any bond or other security) in order to enforce or prevent violation of the provisions of this Agreement. 

 

	13.3	Rules of Construction 

 Defined terms used in this Agreement in the singular shall
import the plural and vice versa. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. All references herein to Parts and Sections shall be deemed to be references to Parts and Sections
of this Agreement, respectively, unless the context shall otherwise require. The words “include,” 

  
 20 

 
“includes” and “including” shall be deemed to be followed by the phrase “without limitation.” The words “hereof,” “herein” and
“hereunder” and words of similar import when used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. Any statute or laws defined or referred to herein shall include any rules,
regulations or forms promulgated thereunder from time to time and as from time to time, amended, amended and restated, modified or supplemented, including by succession of comparable rules, regulations or forms. Unless otherwise expressly provided
herein, any agreement, instrument or statute defined or referred to herein or in any agreement or instrument that is referred to herein means such agreement, instrument or statute as from time to time amended, amended and restated, modified or
supplemented, including (in the case of agreements or instruments) by waiver or consent and (in the case of statutes) by succession of comparable successor statutes and references to all attachments thereto and instruments incorporated therein. Any
reference to the number of shares of capital stock of Ultra means such shares of capital stock of Ultra as appropriately adjusted to give effect to any share combinations or exchanges, restructuring or other recapitalizations of Ultra or its capital
structure. Any reference herein to the holder of a particular class or series of capital stock of Ultra shall be a reference to such Person solely in its capacity as a holder of that particular class or series of such capital stock of Ultra. 

 

	13.4	Amendment and Waiver 

 This Agreement may be amended, modified, extended, terminated or
waived (an “Amendment”), and the provisions hereof may be waived, only by an agreement in writing signed by Ultra and Sponsor. Each such Amendment shall be binding upon each Party hereto. In addition, each Party hereto may waive any
right hereunder, as to itself, by an instrument in writing signed by such Party. The failure of any Party to enforce any provisions of this Agreement shall in no way be construed as a waiver of such provisions and shall not affect the right of such
Party thereafter to enforce each and every provision of this Agreement in accordance with its terms. To the extent the Amendment of any Section of this Agreement would require a specific consent pursuant to this
Section 13.4, any Amendment to the definitions used in such Section as applied to such Section shall also require the same specified consent. 

 

	13.5	Successors and Assigns 

 This Agreement shall be binding upon and inure to the benefit
of and be enforceable by the Parties hereto and their respective successors and assign, including subsequent holders of Registrable Securities to the extent permitted herein. Ultra may not transfer any rights or obligations under this Agreement
without the prior written consent of Sponsor, including that Ultra shall not merge, consolidate, amalgamate, combine or enter into an exchange with any other person, or reorganize or convert to another entity or form, or engage in any similar
transaction, unless the agreement providing for such merger, consolidation, amalgamation, combination, exchange, reorganization, conversion or similar transaction expressly provides for the continuation of the registration rights specified in this
Agreement with respect to the Registrable Securities or other securities issued pursuant to such merger, consolidation, amalgamation, combination, exchange, reorganization, conversion or similar transaction. 

 

	13.6	Severability 

 Whenever possible, each provision of this Agreement shall be interpreted
in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality
or unenforceability shall not affect any other provision or the effectiveness or validity of any provision in any other jurisdiction, and this Agreement shall be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or
unenforceable provision had never been contained herein. 

  
 21 

	13.7	Counterparts 

 This Agreement may be executed in separate counterparts (including by
means of facsimile or electronic transmission in portable document format), each of which shall be an original and all of which taken together shall constitute one and the same Agreement. 

 

	13.8	Descriptive Headings; No Strict Construction 

 The descriptive headings of this
Agreement are inserted for convenience only and do not constitute a part of this Agreement. The Parties hereto agree that they have been represented by counsel during the negotiation and execution of this Agreement and have participated jointly in
the drafting of this Agreement and, therefore, waive the application of any law, holding or rule of construction providing that ambiguities in an agreement or other document will be construed against the Party drafting such agreement or document.

  

	13.9	Notices 

 Any notices and other communications required or permitted in this Agreement
shall be effective if in writing and (a) delivered personally, (b) sent by facsimile or electronic mail, or (c) sent by overnight courier, in each case, addressed as follows: 

Ultra SC Inc. 
 c/o DXC
Technology Company 
 1775 Tysons Boulevard 

Tysons, Virginia 22101 
 Attn:
William L. Deckelman, Jr. 
 Email: bill.deckelman@dxc.com 

with copies to (which shall not constitute notice): 

Latham & Watkins LLP 

885 Third Avenue 
 New York, NY
10022 
 Attention: Peter Harwich 

Email: peter.harwich@lw.com 
 and

 Veritas Capital Fund Management, L.L.C. 

9 West 57th Street, 29th Floor 

New York, NY 10019 

Attn:      Ramzi M. Musallam 

E-mail:  RMusallam@veritascapital.com 

  
 22 

 with a copy to (which shall not constitute notice): 

Skadden, Arps, Slate, Meagher & Flom LLP 

4 Times Square 
 New York, NY
10036 
 Attn:      Kenneth M. Wolff 

E-mail:  Kenneth.Wolff@skadden.com 

with a copy to (which shall not constitute notice): 

Schulte Roth & Zabel LLP 

919 Third Avenue 
 New York, NY
10022 
 Attn:      Richard A. Presutti 

E-mail:  Richard.Presutti@srz.com 

Unless otherwise specified herein, such notices or other communications shall be deemed effective (i) on the date received, if personally
delivered, (ii) on the date received if delivered by facsimile on a Business Day, or if not delivered on a Business Day, on the first Business Day thereafter, and (iii) two Business Days after being sent by overnight courier. Each of the
Parties hereto shall be entitled to specify a different address by giving notice as aforesaid to each of the other Parties hereto. 
  

	13.10	Electronic Delivery 

 This Agreement and any signed agreement or instrument entered into
in connection herewith or contemplated hereby, and any amendments hereto or thereto, to the extent signed and delivered by means of a facsimile machine or electronic mail, shall be treated in all manner and respects as an original agreement or
instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered in person. At the request of any Party hereto or to any such agreement or instrument, each other Party hereto or
thereto shall re-execute original forms thereof and deliver them to all other Parties. No Party hereto or to any such agreement or instrument shall raise the use of a facsimile machine or electronic mail to
deliver a signature or the fact that any signature or agreement or instrument was transmitted or communicated through the use of a facsimile machine or electronic mail as a defense to the formation or enforceability of a contract and each such Party
forever waives any such defense. 
  

	13.11	Governing Law; Consent to Jurisdiction; WAIVER OF JURY TRIAL 

  

	 	(a)	All issues and questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by, and construed in accordance with, the laws of the State of New York.

  

	 	(b)	 The Parties agree that jurisdiction and venue in any action brought by any Party pursuant to this Agreement shall
properly lie exclusively in the United States District Court for the Southern District of New York or any court of the State of New York and any federal or state court located in the State of New York from which appeal therefrom validly lies. By
execution and delivery of this Agreement, each Party irrevocably submits to the jurisdiction of such courts for 

  
 23 

	 	
itself and in respect of its property with respect to such action. The Parties irrevocably agree that venue would be proper in such court, and hereby waive any objection that such court is an
improper or inconvenient forum for the resolution of such action. The Parties further agree that the mailing by certified or registered mail, return receipt requested, of any process required by any such court shall constitute valid and lawful
service of process against them, without necessity for service by any other means provided by statute or rule of court. 

  

	 	(c)	AS A SPECIFICALLY BARGAINED INDUCEMENT FOR EACH OF THE PARTIES TO ENTER INTO THIS AGREEMENT (WITH EACH PARTY HAVING HAD OPPORTUNITY TO CONSULT COUNSEL), EACH OF THE PARTIES EXPRESSLY AND IRREVOCABLY WAIVES THE RIGHT
TO A TRIAL BY JURY IN ANY ACTION OR PROCEEDING UNDER THIS AGREEMENT OR ANY ACTION OR PROCEEDING ARISING OUT OF THE TRANSACTIONS CONTEMPLATED HEREBY OR ANY OTHER TRANSACTION DOCUMENT, REGARDLESS OF WHICH PARTY INITIATES SUCH ACTION OR PROCEEDING, AND
ANY ACTION OR PROCEEDING UNDER THIS AGREEMENT OR ANY ACTION OR PROCEEDING ARISING OUT OF THE TRANSACTIONS CONTEMPLATED HEREBY OR ANY OTHER TRANSACTION DOCUMENT SHALL BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A
JURY. 

  

	13.12	Exercise of Rights and Remedies 

 No delay of or omission in the exercise of any right,
power or remedy accruing to any Party as a result of any breach or default by any other Party under this Agreement shall impair any such right, power or remedy, nor shall it be construed as a waiver of or acquiescence in any such breach or default,
or of any similar breach or default occurring later; nor shall any such delay, omission nor waiver of any single breach or default be deemed a waiver of any other breach or default occurring before or after that waiver. 

 
  

[Signature Page Follows] 

  
 24 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be signed by their respective
officers thereunto duly authorized, as of the date first written above. 
  

					
	ULTRA SC INC.
		
	By:  	 	/s/ William L. Deckelman, Jr.
		 	Name: 	 	William L. Deckelman, Jr.
		 	Title:	 	Vice President & Secretary
	
	VERITAS CAPITAL FUND MANAGEMENT, L.L.C.
		
	By:	 	/s/ Ramzi M. Musallam
		 	Name:	 	Ramzi M. Musallam
		 	Title:	 	Authorized Signatory
	
	THE SI ORGANIZATION HOLDINGS LLC
		
	By:	 	/s/ Ramzi M. Musallam
		 	Name:	 	Ramzi M. Musallam
		 	Title:	 	Authorized Signatory
	
	KGS HOLDING LLC
		
	By:	 	/s/ Ramzi M. Musallam
		 	Name:	 	Ramzi M. Musallam
		 	Title:	 	Authorized Signatory

  
  

[Signature Page to Sponsor Letter Agreement]Exhibit

Exhibit 10.2

EMPLOYMENT AGREEMENT
This Employment Agreement (the “Agreement”), effective the 11 day of December, 2017 (the “Effective Date”), by and between Tyson Foods, Inc., a Delaware corporation, and any of its subsidiaries and affiliates (hereinafter collectively referred to as “Tyson”), and Stewart Glendinning, Persn XXXXXX (hereinafter referred to as “you”).
WITNESSETH:
WHEREAS, Tyson is engaged in a very competitive business, where the development and retention of extensive confidential information, trade secrets and proprietary information as well as customer relationships and goodwill are critical to future business success; and
WHEREAS, by virtue of your employment with Tyson, you are involved in the development of, and have access to, Tyson’s confidential information, trade secrets and proprietary information, and, if such information were to get into the hands of competitors of Tyson, it could do substantial business harm to Tyson; and
WHEREAS, you will not be provided with or given access to Tyson’s customers and goodwill or Tyson’s confidential information, trade secrets and proprietary information unless you execute this Agreement; and
WHEREAS, Tyson has advised you that agreement to the terms of this Agreement, and specifically the non-compete and non-solicitation sections, is an integral part of this Agreement, and you acknowledge the importance of the non-compete and non-solicitation sections, and having reviewed the Agreement as a whole, are willing to commit to the restrictions set forth herein;
NOW, THEREFORE, Tyson and you hereby mutually agree as follows:
1.Employment.  
(a)Consideration. In consideration of the above and other good and valuable consideration, you are expressly being given employment, continued employment, a relationship with Tyson, certain monies, benefits, severance, stock awards, training and/or access to trade secrets and confidential information of Tyson and its customers, suppliers, vendors or affiliates to which you would not have access but for your relationship with Tyson in exchange for you agreeing to the terms of this Agreement.  

Exhibit 10.2

(b)Duties.  Tyson hereby agrees to employ you and you hereby accept employment with Tyson.  The duties and services required to be performed by you shall be consistent with your position, as assigned by Tyson in its sole discretion from time to time, and shall be consistent with the level and responsibility of the duties and services performed by other employees in your job grade level (“Job Grade”).  At Tyson’s sole discretion, both your position and Job Grade are subject to change during your term of employment.  You agree to devote substantially all of your working time, attention and energies to the business of Tyson.  You may make and manage personal investments (provided such investments in other activities do not violate, in any material respect, the provisions of Section 6 of this Agreement), be involved in charitable and professional activities, and, with the prior written consent of Tyson’s General Counsel or Chief Human Resources Officer, serve on boards of other for profit entities, provided such activities do not materially interfere with the performance of your duties hereunder. You agree that during your employment with Tyson, you will not engage in any (i) competitive outside business activities, (ii) outside business that provides goods or services to Tyson, or (iii) outside business that buys products from Tyson, other than with Tyson’s prior written approval. You will devote your best efforts to the performance of your duties and the advancement of Tyson and shall not engage in any other employment, profitable activities, or other pursuits which would cause you to disclose or utilize Confidential Information (as defined in Section 6(a)), or reflect adversely on Tyson.  This obligation shall include, but is not limited to, obtaining Tyson’s consent prior to performing tasks for business associates of Tyson outside of your customary duties for Tyson, giving speeches or writing articles, blogs, or posts, about Tyson’s business, improperly using Tyson’s name or identifying your association or position with Tyson in a manner that reflects unfavorably upon Tyson.  You further agree that you will not use, incorporate, or otherwise create any business entity or organization or domain name using any name confusingly similar to the name of Tyson or the name of any affiliate of Tyson or any other name under which any such entities do business.
(c)Term of Employment. Your employment under this Agreement will commence on the Effective Date above and end on the date your employment terminates pursuant to Section 3 (the “Period of Employment”). 
2.Compensation. 
(a)Initial Consideration.  You shall receive, in addition to all regular compensation for services as described in this Section 2 and the severance and benefits provided under Section 4 and Section 5, $1,000.00 as additional consideration for signing this Agreement and for agreeing to abide and be bound by the terms, provisions and restrictions of Section 6.  You understand and acknowledge that you have been properly and timely informed of the type, amount and terms of such consideration and that you would not be entitled to such consideration, and that such consideration would not be paid, if you did not execute and agree to be bound by the provisions of this Agreement.

Exhibit 10.2

(b)Base Salary.  For the services to be performed hereunder during the Period of Employment, Tyson shall pay you at a base salary of $725,000.00, which may be adjusted by Tyson from time to time within the range paid to other employees in your Job Grade.  Such base salary shall be paid in accordance with Tyson’s payroll practice.
(c)Performance Incentive Eligibility.  You may receive performance incentive awards under Tyson’s annual and long-term incentive plans then in effect (if any), on terms and in amounts consistent with those provided to other employees in your Job Grade, subject to the discretion of the senior management of Tyson. 
(d)Stock Grants.  You may receive stock awards under an equity incentive compensation plan of Tyson then in effect (if any), on terms and in amounts consistent with those provided to other employees in your Job Grade, subject to the discretion of the senior management of Tyson. 
(e)Benefit Plans, Vacation and Reimbursement Programs. You shall be entitled to participate in any benefit plans of Tyson, and its affiliates, as adopted or amended from time to time on terms and in amounts consistent with those generally applicable to other employees in your Job Grade.  You will be entitled to an annual paid vacation in accordance with Tyson’s applicable vacation policy, as in effect from time to time.  Tyson will pay or reimburse you for all reasonable expenses actually incurred or paid by you in the performance of your services to Tyson, subject to and in accordance with applicable expense reimbursement and related policies and procedures as in effect from time to time.
(f)Review.  Base salary, performance incentive compensation, stock grant levels, and plan participation will be subject to review annually (or from time to time at Tyson’s discretion), when compensation of other officers and managers of Tyson are reviewed for consideration of adjustments thereof. 
3.Termination. Upon any termination of your employment for any reason, you shall immediately resign from all boards, offices and other positions with Tyson or from any board or committee of an association or industry group where you represent Tyson.  The date upon which your employment terminates and the Period of Employment ends will be your “Termination Date” for all purposes of this Agreement.  Your employment may be terminated under this Agreement in the following events:
(a)Death.  Your employment hereunder will terminate upon your death.
(b)Disability. Your employment hereunder will terminate upon your “Disability”.  For purposes of this Agreement, Disability has the same meaning as provided in the long-term disability plan or policy maintained or, if applicable, most recently maintained, by Tyson.  If no long-term disability plan or policy was ever maintained on behalf of you or, if the determination of Disability relates to an incentive stock option, Disability means that condition described in Section 22(e)(3) of the Internal Revenue Code (the “Code”), as amended from time to time.  In the event of a dispute, the determination of Disability will be made by the Committee (as defined in Tyson’s equity incentive plan) and will be supported by advice of a 

Exhibit 10.2

physician competent in the area to which such Disability relates.
(c)Termination by You for Good Reason.  Upon the occurrence of a “Good Reason” event, you may terminate your employment pursuant to this Agreement by providing a notice of termination for Good Reason to Tyson within no more than seven (7) days of the Good Reason event and providing Tyson thirty (30) days following receipt of such notice to cure the Good Reason event.  If Tyson cures the Good Reason event within such 30 day period, you may not terminate your employment for Good Reason, but may voluntarily resign pursuant to Section 3(d) below.  If Tyson fails to cure the Good Reason event within such 30 day period, your termination of employment will be effective under this Section 3(c).  For purposes of the Agreement, you will be treated as having terminated for “Good Reason” if you terminate employment after having been demoted to a less senior Job Grade than that in which you were employed immediately prior to the occurrence of the Good Reason event, which Tyson does not cure by restoring you to your former Job Grade.
(d)Voluntary Termination by You without Good Reason.  You may terminate your employment pursuant to this Agreement at any time by not less than thirty (30) days prior written notice to Tyson, which notice period may be waived by Tyson.  Upon receipt of such notice, Tyson shall have the right, at its sole discretion, to accelerate your Termination Date at any time during said notice period.
(e)Termination for Cause by Tyson.  Tyson may terminate your employment hereunder for “Cause” at any time after providing a notice of termination for Cause to you.  For purposes of this Agreement, you shall be treated as having been terminated for Cause if and only if you are terminated as a result of the occurrence of one or more of the following events:
		
	(i)
	any willful and wrongful conduct or omission by you that injures Tyson;

		
	(ii)
	any act by you of intentional misrepresentation or embezzlement, misappropriation or conversion of assets of Tyson;

		
	(iii)
	you are convicted of, confess to, plead no contest to, or become the subject of proceedings that provide a reasonable basis for Tyson to believe that you have been engaged in a felony; or

		
	(iv)
	your intentional or willful violation of any restrictive covenant provided for under Section 6 of this Agreement or any other agreement to which you are a party.

For purposes of this Agreement an act or failure to act shall be considered “willful” only if done or omitted to be done without your good faith reasonable belief that such act or failure to act was in the best interests of Tyson.  In no event shall Tyson’s failure to notify you of the occurrence of any event constituting Cause, or to terminate you as a result of such event, be construed as a consent to the occurrence of future 

Exhibit 10.2

events, whether or not similar to the initial occurrence, or a waiver of Tyson’s right to terminate you for Cause as a result thereof.
(f)Termination by Tyson without Cause.  Tyson may terminate your employment hereunder without Cause at any time upon notice to you.
4.Compensation Following Termination of Employment.  In the event that your employment hereunder is terminated in a manner as set forth in Section 3 above, you shall be entitled to the compensation and benefits provided under this Section 4.  
(a)Termination Due to Death, Disability, Voluntary Termination without Good Reason or Termination for Cause by Tyson.  In the event that your employment is terminated by reason of death, Disability, voluntary termination by you without Good Reason or for Cause by Tyson, Tyson shall pay the following amounts to you or your estate:
		
	(i)
	Any accrued but unpaid base salary for services rendered to the Termination Date, any accrued but unpaid expenses required to be reimbursed under this Agreement, and any vacation accrued to the Termination Date (“Accrued Compensation”); and

		
	(ii)
	Any benefits accrued through the date of termination to which you may be entitled pursuant to the plans, policies and arrangements, as determined and paid in accordance with the terms of such plans, policies and arrangements (“Plan Benefits”).

(b)Termination by Tyson without Cause or by you for Good Reason.  In the event that your employment is terminated by Tyson for reasons other than death, Disability or Cause, or by you for Good Reason, Tyson shall pay the following amounts to you:
		
	(i)
	Accrued Compensation;

		
	(ii)
	Plan Benefits; 

		
	(iii)
	Subject to your execution of the Release (as defined below), you will become vested in a pro rata portion of any of your unvested restricted stock awards that are outstanding on your Termination Date provided the applicable performance criteria, if any, are met.  Such pro rata portion shall be equal to the percentage of the total vesting period, measured in days, in which you remained employed by Tyson multiplied by the number of shares subject to the award.  Any award subject to this subsection (iii) shall not be paid until such time as it would otherwise have been paid if under the terms of the award it was subject to performance criteria and will only be paid if any applicable 

Exhibit 10.2

performance criteria are met; 
		
	(iv)
	Subject to your execution of the Release (as defined below), you will become fully vested in any of your unvested stock options that are outstanding on the Termination Date; and

		
	(v)
	Subject to your execution of the Release (as defined below), you will become entitled to a pro rata portion of any performance share awards that are outstanding on the Termination Date provided the applicable performance criteria is met.  The pro rata portion of your award shall equal the percentage of the total performance period, measured in days, in which you remained employed by Tyson multiplied by the percentage of the award that you would have received had you remained employed for the entire performance period.  Any award subject to this subsection (v) shall not be paid until such time as it would have otherwise been paid under the terms of the award and will only be paid if the performance criteria are met.

		
	(vi)
	Subject to your execution of the Release (as defined below), an amount equal to, and on terms equal to, the severance payments and severance benefits provided to other employees within your Job Grade, as determined under the Tyson Foods Severance Pay Plan for Contracted Employees.  In the event of a Change of Control (defined below) the amount you would be entitled to in the event of termination subject to this Section 4(b) will be based on the Tyson Foods Severance Pay Plan for Contracted Employees in place at the time immediately prior to the Change of Control.

(c)Release.  For purposes of this Agreement, “Release” means that specific document which Tyson shall present to you for consideration and execution after your termination of employment, under which you agree to irrevocably and unconditionally release and forever discharge Tyson, its subsidiaries, affiliates and related parties from any and all causes of action which you at that time had or may have had against Tyson (excluding any claim for indemnity under this Agreement, or any claim under state workers’ compensation or unemployment laws).  The Release will be provided to you as soon as practical after your Termination Date, but in any event in sufficient time so that you will have adequate time to review the Release as provided by applicable law. The Release must be signed within twenty-one (21) days of its presentation to you (or within forty-five (45) days if you are terminated as part of a group termination).  The Release shall not become effective until seven (7) days after it is executed.  Tyson maintains a form of Release, which it may change from time to time as it deems appropriate.  The latest version of the Release shall be available for your review upon request.  Subject to the payment provisions of the Tyson Foods Severance 

Exhibit 10.2

Pay Plan for Contracted Employees and Section 8 below, any payments subject to a Release shall commence on the first payroll period commencing on or after the date the Release becomes effective.   
5.Acceleration of Stock Grants on Change in Control.  Upon the occurrence of a Change in Control (defined below) the stock awards that have been granted to you pursuant to award agreements from Tyson under Section 2, or which have otherwise been previously granted to you under an award agreement from Tyson; and which awards remain outstanding at the time of the Change in Control, will be treated in accordance with the applicable award agreements.  For purposes of this Agreement, the term “Change in Control” shall have the same meaning as set forth in Tyson’s equity incentive compensation plan then in effect; provided, however, that a Change in Control shall not include any event as a result of which one or more of the following persons or entities possess or continues to possess, immediately after such event, over fifty percent (50%) of the combined voting power of the Company or, if applicable, a successor entity: (a) Tyson Limited Partnership, or any successor entity; (b) individuals related to the late Donald John Tyson by blood, marriage or adoption, or the estate of any such individual (including Donald John Tyson’s); or (c) any entity (including, but not limited to, a partnership, corporation, trust or limited liability company) in which one or more of the entities, individuals or estates described in clauses (a) and (b) hereof possess over fifty percent (50%) of the combined voting power or beneficial interests of such entity.  Notwithstanding the foregoing, this Section 5 shall not affect the time or form of payment under an applicable award agreement, and all awards shall be paid at the time, and in the form, provided under the terms of such award agreement.  The Committee (as defined in Tyson’s equity incentive plan) shall have the sole discretion to interpret the foregoing provisions of this paragraph.
6.Restrictive Covenants and Other Restrictions.
(a)Confidential Information.  You acknowledge that during the course of your employment with Tyson, you will be provided, learn, develop and have access to Tyson’s trade secrets, confidential information and proprietary materials which may include, but are not limited to, the following: strategies, methods, books, records, and documents; technical information concerning products, formulas, production, distribution, equipment, services, and processes; procurement procedures and pricing techniques; the names of and other information concerning customers, suppliers, vendors, investors, and other business affiliates (such as contact name, service provided, pricing, type and amount of services used, credit and financial data, and/or other information relating to Tyson’s relationship with that business affiliate); pricing strategies and price curves; positions, plans, and strategies for expansion or acquisitions; budgets; customer lists; research; weather data; financial analysis, returns and reports and sales data; trading methodologies and terms; evaluations, opinions, and interpretations of information and data; marketing and merchandising techniques; prospective customers’ names and marks; grids and maps; electronic databases; models; specifications; computer programs; internal business records; contracts benefiting or obligating Tyson; bids 

Exhibit 10.2

or proposals submitted to any third party; technologies and methods; training methods and training processes; organizational structure; personnel information, including salaries of personnel; payment amounts or rates paid to consultants or other service providers; and other information, whether tangible or intangible, in any form or medium provided (collectively, “Confidential Information”) which is not generally available to the public and which has been developed, will be developed or acquired by Tyson at considerable effort and expense.  Without limiting the foregoing, you acknowledge and agree that you will learn, be provided, develop and have access to certain techniques, methods or applications implemented or developed by Tyson which are not generally known to the public or within the community in which Tyson competes, and any and all such information shall be treated as Confidential Information.  
During the term of this Agreement or at any time thereafter, unless otherwise specifically authorized in writing by Tyson, you hereby covenant and agree: (i) to hold Confidential Information in the strictest confidence; (ii) not to, directly or indirectly, disclose, divulge or reveal any Confidential Information to any person or entity other than as authorized by Tyson; (iii) to use such Confidential Information only within the scope of your employment with Tyson for the benefit of Tyson; and (iv) to take such protective measures as may be reasonably necessary to preserve the secrecy and interest of Tyson in the Confidential Information. You agree to immediately notify Tyson of any unauthorized disclosure or use of any Confidential Information of which you become aware.  The confidentiality obligations herein shall not prohibit you from revealing evidence of criminal wrongdoing to legitimate law enforcement officials or Confidential Information by order of court or agency of competent jurisdiction or as otherwise required by law; however, you shall promptly inform Tyson of any such situations and shall take reasonable steps to prevent disclosure of Confidential Information until Tyson has been informed of such required disclosure and has had a reasonable opportunity first to seek a protective order.
(b)Creative Works.  “Creative Works” include, but are not limited to, all original works of authorship, inventions, discoveries, designs, computer hardware and software, algorithms, programming, scripts, applets, databases, database structures, or other proprietary information, business ideas, and related improvements and devices, which are conceived, developed, or made by you, either alone or with others, in whole or in part, on or off Tyson’s premises, (i) during your employment with Tyson, (ii) with the use of the time, materials, or facilities of Tyson, (iii) relating to any product, service, or activity of Tyson of which you have knowledge, or (iv) suggested by or resulting from any work performed by you for Tyson.  Creative Works do not include inventions or other works developed by you entirely on your own time without using Tyson’s equipment, supplies, facilities, or trade secret information except for those inventions or works developed during your Period of Employment that either: (a) relate at the time of conception or reduction to practice of the 

Exhibit 10.2

invention to Tyson’s business, or actual or demonstrably anticipated research or development of Tyson; or (b) result from any work performed by you for Tyson.  If you are or become a resident of any state during your employment that has enacted laws relating to ownership of works created without use of or reference to Tyson materials, facilities, and/or intellectual property and do not relate to Tyson’s business, this Section shall be limited solely to the extent provided by the applicable laws of such states.
To the extent any rights in the Creative Works are not already owned by Tyson, you irrevocably assign and transfer to Tyson all proprietary rights, including, but not limited to, all patent, copyright, trade secret, trademark, and publicity rights, in the Creative Works and agree that Tyson will be the sole and exclusive owner of all right, title, and interest in the Creative Works.  Tyson will have the right to use all Creative Works, whether original or derivative, in any manner whatsoever and in any medium now known or later developed.  You agree not, at any time, to assert any claim, ownership, or other interest in any of the Creative Works or Confidential Information.
Both during and after your employment, you agree to execute any documents necessary to effectuate the assignment to Tyson of the Creative Works, and will execute all papers and perform any other lawful acts reasonably requested by Tyson for the preparation, prosecution, procurement, and maintenance of any trademark, copyright, and/or patent rights in and for the Creative Works.  You further agree that you will not be entitled to any compensation in addition to the salary paid to you during the development of the Creative Works.  In the event Tyson is unable for any reason to secure your signature to any document Tyson reasonably requests you to execute under this Section 6, you hereby irrevocably designate and appoint Tyson and its authorized officers and agents as your agents and attorneys-in-fact to act for and in your behalf and instead of you to execute such document with the same legal force and effect as if executed by you.
(c)No Restrictions on Employment.  You are being employed or continuing to be employed by Tyson with the understanding that (i) you are free to enter into employment or continued employment with Tyson, (ii) your employment with Tyson will not violate any agreement you may have with a third party (e.g., existing employment, non-compete, intellectual property ownership, and/or non-disclosure agreements) and (iii) only Tyson is entitled to the benefit of your work.  If you have any agreements with a prior employer, you are required to provide such agreements to Tyson prior to executing this Agreement.  Tyson has no interest in using any other person’s patents, copyrights, trade secrets, or trademarks in an unlawful manner.  You should be careful not to disclose to Tyson any intellectual property or confidential information of your prior employers or anyone else or misapply proprietary rights that Tyson has no right to use and you further represent and warrant that you have either already returned or have coordinated the return of all such information to any 

Exhibit 10.2

prior employer.
(d)Removal and Return of Tyson Property.  All written materials, records, data, and other documents prepared or possessed by you during your employment with Tyson are Tyson’s property. All memoranda, notes, records, files, correspondence, drawings, manuals, models, specifications, computer programs, maps, and all other documents, data, or materials of any type embodying such information, ideas, concepts, improvements, discoveries, and inventions are Tyson’s property. You agree not to remove any property of Tyson, including, but not limited to, any Confidential Information or Creative Works, from Tyson’s premises, except as authorized under Tyson’s policies or with the prior written approval of Tyson’s General Counsel or Chief Human Resources Officer.  Unless specifically authorized by Tyson in writing, you may not place Tyson Confidential Information or Creative Works on Removable Media, as defined below.  On Tyson’s request, your acceptance of other employment, or the termination of your employment for any reason, you will immediately return to Tyson all Tyson property, including all Confidential Information and Creative Works and any and all documents and materials that contain, refer to, or relate in any way to any Confidential Information, as well as any other property of Tyson in your possession or control, including all electronic and telephonic equipment, credit cards, security badges, and passwords.  You will permit Tyson to inspect any property provided by Tyson to you or developed by you as a result of or in connection with your employment with Tyson when you accept other employment or otherwise separate from your employment, regardless of where the property is located.  For purposes of this Section, “Removable Media” means portable or removable hard disks, floppy disks, USB memory drives, zip disks, optical disks, CDs, DVDs, digital film, memory cards (e.g., Secure Digital (SD), Memory Sticks (MS), CompactFlash (CF), SmartMedia (SM), MultiMediaCard (MMC), and xD-Picture Card (xD)), magnetic tape, and all other removable data storage media.
(e)Non-Competition.  You acknowledge that Tyson performs services throughout the United States and that your duties and services impact Tyson’s performance of services throughout the United States.  Accordingly, you acknowledge the need for certain restrictions contained in this Agreement to be without limitation as to location or geography within the United States.  You agree that during your employment with Tyson, and for a period of 12 months thereafter, you will not directly or indirectly, on behalf of yourself or in conjunction with any other person, company or entity, own (other than less than 5% ownership in a publicly traded company), manage, operate, or participate in the ownership, management, operation, or control of, or be employed by or a consultant to any person, company or entity which is in competition with Tyson, with which you would hold a position with responsibilities similar to any position you held with Tyson during the 24 months preceding your Termination Date or in which you would utilize or disclose confidential methodologies, techniques, customer lists or information of Tyson.  You agree that during your employment with Tyson and for a period of 12 months thereafter you will not directly or indirectly, 

Exhibit 10.2

on behalf of you or any other person, company or entity, participate in the planning, research or development of any strategies or methodologies, similar to strategies or methodologies, utilized or developed by Tyson, excluding general industry knowledge, for which you had access to, utilized or developed during the 36 months preceding your Termination Date.  You agree that nothing in this Section shall limit your confidentiality obligations in this Agreement.  Further, you understand and agree that during your employment and the restricted time periods thereafter designated in this Agreement, while you may gather information to investigate other employment opportunities, you shall not make plans or prepare to compete, solicit or take on activities which are in violation of this Agreement.  Should you leave Tyson and accept employment or a consulting position with a competitor, you are required beforehand to inform Tyson of the identity of your new employer and your responsibilities for the new employer.  You are also required to show this Agreement to all new employers prior to accepting new employment and Tyson shall also be permitted to show this Agreement to all new employers as well.
(f)Non-Solicitation.  You agree that during your employment with Tyson and for a period of 36 months thereafter, you will not, nor will you assist any third party to, directly or indirectly (i) raid, hire, solicit, encourage or attempt to persuade any employee or independent contractor of Tyson, or any person who was an employee or independent contractor of Tyson during the 6 months preceding the Termination Date, who possesses or had access to Confidential Information of Tyson, to leave the employ of or terminate a relationship with Tyson; (ii) interfere with the performance by any such persons of their duties for Tyson; (iii) communicate with any such persons for the purposes described in the paragraph above; or (iv) solicit, encourage or attempt to persuade any customer or vendor of Tyson during the 6 months preceding your Termination Date to terminate or modify its relationship with Tyson.
(g)Non-Disparagement.  You agree that you shall not at any time engage in any form of conduct, or make any statement or representation, either oral or written, that disparages, impugns or otherwise impairs the reputation, goodwill or interests of Tyson, or any of its officers, directors, shareholders, managing members, representatives, and/or employees or agents in either the individual or representative capacities of any of the foregoing individuals (including, without limitation, the repetition or distribution of derogatory rumors, allegations, negative reports or comments). Nor shall you direct, arrange or encourage others to make any such derogatory or disparaging statements on your behalf.  Nothing in this Section, however, shall prevent you from providing truthful testimony or information in any proceeding or in response to any request from any governmental agency, or judicial, arbitral or self-regulatory forum.
(h)Effect of Breach.  You acknowledge and agree that, in the event of any breach by you of the terms and conditions of this Agreement, pursuant to the terms of certain benefit plans and programs, your accrued benefits thereunder may be discontinued or forfeited, in addition to any other rights and remedies Tyson may have at law or in equity.  You acknowledge that irreparable damage would result to Tyson if the 

Exhibit 10.2

provisions of this Agreement are not specifically enforced, and that, in addition to any other legal or equitable relief available, and notwithstanding any alternative dispute resolution provisions that have been or may be agreed to between Tyson and you, Tyson shall be entitled to injunctive relief in the event of any failure to comply with the provisions of this Agreement.  If you violate any of the terms of this Agreement, you will indemnify Tyson for the expenses, including but not limited to reasonable attorneys’ fees, incurred by Tyson in enforcing this Agreement.
(i)Clawback Policies. In addition to subsection (h) above, any amounts payable under this Agreement are subject to any policy, whether in existence as of the Effective Date or later adopted, established by Tyson that provides for the clawback or recovery of amounts that were paid to you under circumstances requiring clawback or recovery as set forth in such policy.  Tyson will make any determinations for clawback or recover in its sole discretion and in accordance with any applicable law or regulation.  Further, notwithstanding any other provisions of this Agreement, if within one year of the termination of your employment, Tyson becomes aware of facts that would have allowed Tyson to terminate your employment for Cause (within the meaning of Section 3), then, to the extent permitted by law:
		
	(i)
	Tyson may elect to cancel any and all payments of benefits otherwise due to you, but not yet paid, under this Agreement or otherwise; and

		
	(ii)
	you will refund to Tyson any amounts, plus interest, previously paid by Tyson to you in excess of your Accrued Compensation and Plan Benefits (within the meaning of Section 4).  

7.General.  
(a)Enforcement and Severability. You specifically acknowledge and agree that the purpose of the restrictions contained in this Agreement is to protect Tyson from unfair competition, including improper use of the Confidential Information by you, and that the restrictions and covenants contained herein are reasonable with respect to both scope and duration of application.  Notwithstanding the foregoing, if any court determines that any of the terms herein are unreasonable, invalid or unenforceable, the court may interpret, alter, amend or modify any or all of the terms to include as much of the scope, time period and intent as will render the restrictions enforceable, and then as modified, enforce the terms.  Each covenant and restriction contained in this Agreement is independent of each other such covenant and restriction, and if any such covenant or restriction is held for any reason to be invalid, unenforceable and incapable of corrective modification, then the invalidity or unenforceability of such covenant or restriction shall not invalidate, affect or impair in any way the validity and enforceability of any other such covenant or restriction.  
(b)Notices.  All written notices, requests and other communications provided pursuant to this Agreement shall be deemed to have been duly given, if delivered in person or by courier, or by facsimile 

Exhibit 10.2

transmission or sent by express, registered or certified mail, postage prepaid addressed, if to you, at the most recent address on record in Tyson’s human resources information system, and if to Tyson, at its headquarters: 
Tyson Foods, Inc.
Attn: Chief Human Resources Officer
2200 Don Tyson Parkway
Springdale, Arkansas 72762-6999
(c)Modification.  This Agreement contains all the terms and conditions agreed upon by the parties hereto, and no other agreements, oral or otherwise, regarding the subject matter of this Agreement shall be deemed to exist or bind either of the parties hereto, except for any pre-employment confidentiality agreement that may exist between the parties or any agreement or policy specifically referenced herein. This Agreement cannot be modified except by a writing signed by both parties.
(d)Assignment.  This Agreement shall be binding upon you, your heirs, executors and personal representatives and upon Tyson, its successors and assigns. You acknowledge that the services to be rendered by you are unique and personal. You may not assign, transfer or pledge your rights or delegate your duties or obligations under this Agreement, in whole or in part, without first obtaining the written consent of Tyson’s General Counsel or Chief Human Resources Officer.
(e)Applicable Law.  You acknowledge that this Agreement is performable at various locations throughout the United States and specifically performable wholly or partly within the State of Arkansas and consent to the validity, interpretation, performance and enforcement of this Agreement being governed by the internal laws of said State of Arkansas, without giving effect to the conflicts of laws provisions thereof.
(f)Jurisdiction and Venue of Disputes.  The courts of Washington County, Arkansas shall have exclusive jurisdiction and be the venue of all disputes between Tyson and you, whether such disputes arise from this Agreement or otherwise.  In addition, you expressly waive any right that you may have to sue or be sued in the county of your residence and consent to venue in Washington County, Arkansas.
(g)Funding.  All payments provided under this Agreement, other than payments made pursuant to a plan which provides otherwise, shall be paid from the general funds of Tyson, and no special or separate fund shall be established, and no other segregation of assets made, to assure payment.  You shall have no right, title or interest whatever in or to any investments which Tyson may make to aid Tyson in meeting its obligations hereunder.  To the extent that any person acquires a right to receive payments from Tyson hereunder, such right shall be no greater than the right of an unsecured creditor of Tyson. 

Exhibit 10.2

8.Special Tax Considerations.
(a)Tax Withholding.  Tyson shall provide for the withholding of any taxes required to be withheld by federal, state and local law with respect to any payments in cash and/or other property made by or on behalf of Tyson to or for your benefit under this Agreement or otherwise. 
(b)Excise Tax.    Notwithstanding the foregoing, if the total payments to be paid to you under this Agreement, along with any other payments to you by Tyson, would result in you being subject to the excise tax imposed by Section 4999 of the Code (commonly referred to as the “Golden Parachute Tax”), Tyson shall reduce the aggregate payments to the largest amount which can be paid to you without triggering the excise tax, but only if and to the extent that such reduction would result in you retaining larger aggregate after-tax payments. The determination of the excise tax and the aggregate after-tax payments to be received by you will be made by Tyson. If payments are to be reduced, the payments made latest in time will be reduced first and if payments are to be made at the same time, non-cash payments will be reduced before cash payments.
(c)Separation from Service.  In the event that the termination of your employment does not constitute a “separation from service” as defined in Code Section 409A, including all regulations and other guidance issued pursuant thereto, your rights to the payments and benefits described in Section 4 will vest upon the Termination Date, but no payment to you that is subject to Code Section 409A will be paid until you incur a separation from service (or until six (6) months after such date if you are a “specified employee” pursuant to subsection (d) of this Section), and any amounts that would otherwise have been paid before such date will be paid instead as soon as practicable after such date.
(d)Six-Month Delay in Payment.  Notwithstanding anything to the contrary in this Agreement, if you are a “specified employee” as defined and applied in Code Section 409A as of your Termination Date, then, to the extent any payment under this Agreement or any Tyson plan or policy constitutes deferred compensation (after taking into account any applicable exemptions from Code Section 409A, including those specified in subsection (f) of this Section) and to the extent required by Code Section 409A, no payments due under this Agreement or any Tyson plan or policy may be made until the earlier of: (i) the first (1st) day following the six (6) month anniversary of your Termination Date and (ii) your date of death; provided, however, that any payments delayed during the six (6) month period will be paid in the aggregate as soon as reasonably practicable following the six (6) month anniversary of your Termination Date.
(e)Expense Reimbursement.   In no event will an expense be reimbursed after December 31 of the calendar year following the calendar year in which the expense was incurred.  You are not permitted to receive a payment or other benefit in lieu of reimbursement under Section 2(e). 
(f)Application of Exemptions.  For purposes of Code Section 409A, each “payment” (as defined by Code Section 409A) made under this Agreement will be considered a “separate payment.”  In 

Exhibit 10.2

addition, for purposes of Code Section 409A, each such payment will be deemed exempt from Code Section 409A to the fullest extent possible under (i) the “short-term deferral” exemption of Treasury Regulation § 1.409A-1((b)(4), and (ii) with respect to any additional amounts paid no later than the second (2nd) calendar year following the calendar year containing your Termination Date, the “involuntary separation” pay exemption of Treasury Regulation § 1.409A-1(b)(9)(iii), which are hereby incorporated by reference.
(g)Effect of Release.  Any amounts that are not exempt from Code Section 409A under paragraph (f) above, and which are paid subject to your execution of a Release that provides for a consideration period and revocation period that crosses two calendar years, shall be paid on the first payroll date in the second calendar year that occurs on or after the expiration of the revocation period, regardless of the date the Release is signed.
(h)Interpretation and Administration of Agreement.  To the maximum extent permitted by law, this Agreement will be interpreted and administered in such a manner that the payments to you are either exempt from, or comply with, the requirements of Code Section 409A.
SIGNATURE PAGE FOLLOWS
IN WITNESS WHEREOF, the parties hereto have executed this Agreement effective as of the day and year first above written.
YOU ACKNOWLEDGE THAT YOU HAVE COMPLETELY READ THE ABOVE, HAVE BEEN ADVISED TO CONSIDER THIS AGREEMENT CAREFULLY, AND HAVE BEEN FURTHER ADVISED TO REVIEW IT WITH LEGAL COUNSEL OF YOUR CHOOSING BEFORE SIGNING. YOU FURTHER ACKNOWLEDGE THAT YOU ARE SIGNING THIS AGREEMENT VOLUNTARILY, AND WITHOUT DURESS, COERCION, OR UNDUE INFLUENCE AND THEREBY AGREE TO ALL OF THE TERMS AND CONDITIONS CONTAINED HEREIN.
    
(Employee)    /s/ Stewart Glendinning
(Location)      Springdale Corporate  
(Date)          12/11/2017                   
Tyson Foods, Inc.
By     /s/ Mary Oleksiuk
Title     Executive Vice President and Chief Human Resources Officer

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00278-of-00352.parquet"}]]